Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Formaldehyde | HCID 712 | — |
| Reactant | Citalopram | HCID 2771 | — |
| Reactant | Oxalic acid dihydrate | HCID 61373 | — |
| Reactant | HCID 12986614 | HCID 12986614 | — |
| Solvent | Formic Acid | HCID 284 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | Escitalopram Oxalate | HCID 146571 | 79.3% |
Reaction Steps
To the crude Citalopram (90 g, 0.28 mol) having desmethyl citalopram (7%, HPLC), formic acid (98%, 2.7 g) was added followed by aqueous formaldehyde (35%, 2.37 g). The reaction mass was heated at 85-95° C. for 30 min. HPLC indicated complete conversion of desmethyl impurity into Citalopram. The reaction mass was cooled to 30° C. and diluted with ethanol (900 ml). Oxalic acid dihydrate (41.94 g, 0.33 mol) was added and mass was heated to reflux. The obtained solution was cooled to 20-25° C. and stirring was continued for 2 hours at 20-25° C. The product thus obtained was filtered and crystallized from ethanol to provide highly pure 92 g of crystalline Citalopram oxalate having HPLC purity 99.7% and desmethyl citalopram impurity: Not Detected.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06781003B1 |
|---|
| Source dataset | uspto-grants-2004_08 |
|---|
| ORD ID | ord-edaaef0c570843d3b4150dc7176f65b4 |
|---|
| Source note | uspto-grants-2004_08 |
|---|